通脉养心丸调控动力相关蛋白1介导线粒体动力学减轻心肌细胞损伤OA
Tongmai Yangxin Pill Attenuates Cardiomyocyte Injury by Regulating Drp1-Mediated Mitochondrial Dynamics
目的 探讨通脉养心丸改善缺氧/复氧(HR)诱导的心肌细胞损伤的作用机制.方法 H9C2心肌细胞分为阴性对照(NC,H9C2-NC细胞+10%空白血清)、H/R组(H9C2-NC细胞+10%空白血清)、H/R+TMYXP(H9C2-NC细胞+10%含药血清)、H/R+动力相关蛋白1(Drp1)-Sh(Drp1沉默H9C2 细胞+10%空白血清)、H9C2-Drp1-OE(Drp1 过表达 H9C2 细胞+10%空白血清)、H/R+Drp1-OE+TMYXP组(Drp1过表达H9C2细胞+10%含药血清),培养24 h后,除NC组外接受缺氧2 h复氧12 h建立心肌缺血再灌注损伤模型.ELISA法、比色法分别检测细胞心肌肌钙蛋白I(cTn-I)、肌酸激酶同工酶(CK-MB)、乳酸脱氢酶(LDH)表达;流式技术检测细胞凋亡率及线粒体膜电位、线粒体通透性转换酶(mPTP)开放水平;荧光探针观察线粒体形态;Western Blot与RT-PCR检测心肌细胞凋亡、线粒体动力学相关蛋白及mRNA表达.结果 H/R组线粒体网络断裂显著、发生显著碎片化,荧光信号呈离散点状或短棒状,部分线粒体出现嵴结构模糊及外膜肿胀,H/R+TMYXP组、H/R+Drp1-Sh组较H/R组改善;H/R+Drp1-OE组线粒体超微结构损伤显著,且伴随空泡化改变,H/R+Drp1-OE+TMYXP组较H/R+Drp1-OE组改善.与NC组比较,H/R组总体和早期凋亡率、心肌细胞cTn-I、CK-MB、LDH表达、mPTP开放、剪切型胱天蛋白酶(Cleaved-Caspase)3、Cleaved-Caspase9、淋巴瘤2相关X蛋白(Bax)、Drp1、p-Drp1616、线粒体裂变1蛋白(Fis1)、线粒体裂变因子(Mff)蛋白及细胞色素C(Cyt-C)、凋亡蛋白酶激活因子1(Apaf-1)、Drp1、Fis1、Mff mRNA表达增加,心肌细胞线粒体膜电位、B细胞淋巴瘤 2(Bcl-2)、p-Drp1637、视神经萎缩 1(OPA1)蛋白及 OPA1 mRNA 表达降低(P<0.05,P<0.01).与H/R组比较,H/R+TMYXP组、H/R+Drp1-Sh组上述指标不同程度改善,H/R+Drp1-OE组不同程度加重(P<0.05,P<0.01).与 H/R+Drp1-OE 组比较,H/R+Drp1-OE+TMYXP 组上述指标不同程度改善(P<0.05,P<0.01).结论 通脉养心丸通过调控Drp1介导的线粒体动力学失衡进而减少心肌凋亡,从而减轻H/R诱导的心肌细胞损伤.
Objective To investigate the mechanism of Tongmai Yangxin Pill(TMYXP)in ameliorating hypoxia/reoxygenation(H/R)-induced cardiomyocyte injury.Methods H9C2 cardiomyocytes were divided into the following groups:negative control(NC,H9C2-NC cells+10%blank serum),H/R(H9C2-NC cells+10%blank serum),H/R+TMYXP(H9C2-NC cells+10%drug-containing serum),H/R+dynamin-related protein1(Drp1)-Sh(Drp1-silenced H9C2 cells+10%blank serum),H/R+Drp1-OE(Drp1-overexpressing H9C2 cells+10%blank serum),and H/R+Drp1-OE+TMYXP(Drp1-overexpressing H9C2 cells+10%drug-containing serum).After 24 h of culture,all groups except NC were subjected to 2 h of hypoxia followed by 12 h of reoxygenation to establish a myocardial ischemia-reperfusion injury model.The expression of cardiac troponin I(cTn-I),creatine kinase isoenzyme MB(CK-MB),and lactate dehydrogenase(LDH)was measured by ELISA and colorimetric assays.Apoptosis rate,mitochondrial membrane potential,and mitochondrial permeability transition pore(mPTP)opening were detected by flow cytometry.Mitochondrial morphology was observed using fluorescent probes.Western Blot and RT-PCR were performed to assess the expression of apoptosis-related and mitochondrial dynamics-related proteins and mRNAs.Results In the H/R group,mitochondrial network was severely fragmented,fluorescence signals appeared as discrete dots or short rods,and partial mitochondria exhibited blurred cristae and swollen outer membranes.These alterations were ameliorated in the H/R+TMYXP and H/R+Drp1-Sh groups.The H/R+Drp1-OE group showed aggravated ultrastructural damage with vacuolization,which was improved in the H/R+Drp1 OE+TMYXP group.Compared with the NC group,the H/R group exhibited increased overall and early apoptosis rates,elevated expression of cTnI,CK-MB,LDH,mPTP opening,Cleaved Caspase3,Cleaved Caspase9,B-cell lymphoma-2 associated X(Bax),Drp1,pDrp1616,mitochondrial fission protein 1(Fis1),mitochondrial fission factor(Mff)proteins,and cytochrome C(Cyt-C),apoptotic protease-activating factor 1(Apaf-1),Drp1,Fis1,Mff mRNAs,while mitochondrial membrane potential and the expression of B-cell lymphoma-2(Bcl-2),pDrp1637,optic atrophy 1(OPA1)proteins and OPA1 mRNA were decreased(P<0.05,P<0.01).Compared with the H/R group,the H/R+TMYXP and H/R+Drp1Sh groups showed varying degrees of improvement in the above indicators,whereas the H/R+Drp1-OE group showed aggravated injury(P<0.05,P<0.01).Compared with the H/R+Drp1-OE group,the H/R+Drp1-OE+TMYXP group demonstrated significant improvement in these indices(P<0.05,P<0.01).Conclusion MYXP may exert cardioprotective effects against H/R injury by inhibiting Drp1-mediated mitochondrial excessive fission,restoring mitochondrial dynamics balance,and suppressing the mitochondrial apoptotic pathway.
于瑞;王永霞;王建茹;董政委;高原;朱明军
河南中医药大学第一附属医院心脏中心(郑州 450000)河南中医药大学第一附属医院心脏中心(郑州 450000)||河南中医药大学科技处(郑州 450000)河南中医药大学第一附属医院心脏中心(郑州 450000)河南中医药大学第一附属医院心脏中心(郑州 450000)河南中医药大学第一附属医院心脏中心(郑州 450000)河南中医药大学第一附属医院心脏中心(郑州 450000)
通脉养心丸动力相关蛋白1线粒体动力学缺氧/复氧细胞凋亡心肌细胞
Tongmai Yangxin Pilldynamin-related protein1mitochondrial dynamicshypoxia/reoxygenationapoptosiscardiomyocyte
《中国中西医结合杂志》 2026 (3)
302-309,8
国家科技重大专项(No.2024ZD0522000)国家自然科学基金项目(No.82074229)河南省科技攻关项目(No.212102311079,No.252102310470)河南省中医药科研专项(No.2024ZY3027)河南省青年人才托举项目(No.2024HYTP043)
评论